Evidence map›Paper›PMID 30284703›Full record

ArticleClinical journal of gastroenterology2019

An extremely rare case who underwent total remnant pancreatectomy due to recurrent pancreatic metastasis of intraductal tubulopapillary neoplasm.

Akira Umemura, Kazuyuki Ishida, Hiroyuki Nitta, Takeshi Takahara, Yasushi Hasegawa, Kenji Makabe, Tamotsu Sugai, Akira Sasaki

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Akira UmemuraDepartment of Surgery, Iwate Medical University, 19-1 Uchimaru, Morioka, 020-8505, Japan. aumemura@iwate-med.ac.jp.ORCID http://orcid.org/0000-0003-4181-7159
Kazuyuki IshidaDepartment of Molecular Diagnostic Pathology, Iwate Medical University, Morioka, 020-8505, Japan.
Hiroyuki NittaDepartment of Surgery, Iwate Medical University, 19-1 Uchimaru, Morioka, 020-8505, Japan.
Takeshi TakaharaDepartment of Surgery, Iwate Medical University, 19-1 Uchimaru, Morioka, 020-8505, Japan.
Yasushi HasegawaDepartment of Surgery, Iwate Medical University, 19-1 Uchimaru, Morioka, 020-8505, Japan.
Kenji MakabeDepartment of Surgery, Iwate Medical University, 19-1 Uchimaru, Morioka, 020-8505, Japan.
Tamotsu SugaiDepartment of Molecular Diagnostic Pathology, Iwate Medical University, Morioka, 020-8505, Japan.
Akira SasakiDepartment of Surgery, Iwate Medical University, 19-1 Uchimaru, Morioka, 020-8505, Japan.
Iwate Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe a rare case of recurrent pancreatic metastasis of intraductal tubulopapillary neoplasm (ITPN). A 53-year-old woman diagnosed with an intraductal papillary mucinous neoplasm (IPMN) and a pancreatic ductal adenocarcinoma (PDAC) of the pancreatic body underwent a distal pancreatectomy. The tumor was composed of cuboidal, high-grade dysplastic cells proliferating in a tubulopapillary growth pattern without mucin production; hence, the final diagnosis was ITPN. A follow-up computed tomography scan revealed an enhanced 2 cm mass of the pancreatic head 3 years after the surgery. From workup investigations, the patient was diagnosed with PDAC or a recurrent ITPN of the remnant pancreas. A total remnant pancreatectomy was then performed. Histopathological findings revealed that the new ITPN had the same features as the prior ITPN. In IPMNs, the presence of an invasive component and high-grade dysplasia can lead to progression to a recurring IPMN and the development of PDAC. Because there have been few reports of recurrent ITPN developing into PDAC, the risk factors for ITPN have not been investigated. Because of the uncertain clinicopathological characteristics of ITPN, more data should be gathered to assess the long-term outcome and malignant potential of ITPN.

Indexed as

PancreatectomyAdenocarcinoma, MucinousCarcinoma, Pancreatic DuctalCarcinoma, PapillaryHumansMiddle AgedNeoplasm Recurrence, LocalPancreatic NeoplasmsRisk FactorsIntraductal tubulopapillary neoplasmPancreatic intraductal neoplasmRecurrenceTubulopapillary growth

Identifiers

PMID30284703
OpenAlexW2894766174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.